Log in

Bovine holo-lactoferrin inhibits migration and invasion in MDA-MB-231 breast cancer cells

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Purpose

Breast cancer is the most common malignancy in developed countries and the main cause of deaths in women worldwide. Lactoferrin (Lf) is an iron-binding protein constituted for a single polypeptide chain that is folded into two symmetrical lobes that bind Fe2+ or Fe3+. Lf has the ability to reversibly bind Fe3+ and is found free of Fe3+ (Apo-Lf) or associated with Fe3+ (Holo-Lf) with a different three-dimensional conformation. However, the role of bovine Apo-Lf (Apo-BLf) and bovine Holo-Lf (Holo-BLf) in the migration and invasion induced by linoleic acid (LA) and fetal bovine serum (FBS), as well as in the expression of mesenchymal and epithelial proteins in breast cancer cells has not been studied.

Methods and results

Scratch wound assays demonstrated that Holo-BLf and Apo-BLf do not induce migration, however they differentially inhibit the migration induced by FBS and LA in breast cancer cells MDA-MB-231. Western blot, invasion, zymography and immunofluorescence confocal microscopy assays demonstrated that Holo-BLf partly inhibit the invasion, FAK phosphorylation at tyrosine (Tyr)-397 and MMP-9 secretion, whereas it increased the number and size of focal adhesions induced by FBS in MDA-MB-231 cells. Moreover, Holo-BLf induced a slight increase of E-cadherin expression in MCF-7 cells, and inhibited vimentin expression in MCF-7 and MDA-MB-231 breast cancer cells.

Conclusion

Holo-BLf inhibits cellular processes that mediate the invasion process in breast cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    Article  Google Scholar 

  2. Albuquerque RC, Baltar VT, Marchioni DM (2014) Breast cancer and dietary patterns: a systematic review. Nutr Rev 72:1–17

    Article  Google Scholar 

  3. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F (2019) Breast cancer. Nat Rev Dis Primers 5:66

    Article  Google Scholar 

  4. Chajes V, Romieu I (2014) Nutrition and breast cancer. Maturitas 77:7–11

    Article  CAS  Google Scholar 

  5. Gonzalez-Chavez SA, Arevalo-Gallegos S, Rascon-Cruz Q (2009) Lactoferrin: structure, function and applications. Int J Antimicrob Agents 33:301e301–301e308

    Article  Google Scholar 

  6. Schanbacher FL, Goodman RE, Talhouk RS (1993) Bovine mammary lactoferrin: implications from messenger ribonucleic acid (mRNA) sequence and regulation contrary to other milk proteins. J Dairy Sci 76:3812–3831

    Article  CAS  Google Scholar 

  7. van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK (2001) Antiviral activities of lactoferrin. Antiviral Res 52:225–239

    Article  Google Scholar 

  8. Alexander DB, Iigo M, Yamauchi K, Suzui M, Tsuda H (2012) Lactoferrin: an alternative view of its role in human biological fluids. Biochem Cell Biol 90:279–306

    Article  CAS  Google Scholar 

  9. Conneely OM (2001) Antiinflammatory activities of lactoferrin. J Am Coll Nutr 20:389S–395S discussion 396S-397S

    Article  CAS  Google Scholar 

  10. Hao L, Shan Q, Wei J, Ma F, Sun P (2019) Lactoferrin: Major Physiological Functions and Applications. Curr Protein Pept Sci 20:139–144

    Article  CAS  Google Scholar 

  11. Gruden S, Poklar Ulrih N (2021): Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides.Int J Mol Sci 22

  12. Cutone A, Rosa L, Ianiro G, Lepanto MS, Bonaccorsi di Patti MC, Valenti P, Musci G (2020): Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action. Biomolecules 10

  13. Iigo M, Alexander DB, Long N, Xu J, Fukamachi K, Futakuchi M, Takase M, Tsuda H (2009) Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine. Biochimie 91:86–101

    Article  CAS  Google Scholar 

  14. Tsuda H, Sekine K, Fujita K, Ligo M (2002) Cancer prevention by bovine lactoferrin and underlying mechanisms–a review of experimental and clinical studies. Biochem Cell Biol 80:131–136

    Article  CAS  Google Scholar 

  15. Xu XX, Jiang HR, Li HB, Zhang TN, Zhou Q, Liu N (2010) Apoptosis of stomach cancer cell SGC-7901 and regulation of Akt signaling way induced by bovine lactoferrin. J Dairy Sci 93:2344–2350

    Article  CAS  Google Scholar 

  16. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y (1999) Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem 74:486–498

    Article  CAS  Google Scholar 

  17. Duarte DC, Nicolau A, Teixeira JA, Rodrigues LR (2011) The effect of bovine milk lactoferrin on human breast cancer cell lines. J Dairy Sci 94:66–76

    Article  CAS  Google Scholar 

  18. Avalos-Gomez C, Reyes-Lopez M, Ramirez-Rico G, Diaz-Aparicio E, Zenteno E, Gonzalez-Ruiz C, de la Garza M (2020) Effect of apo-lactoferrin on leukotoxin and outer membrane vesicles of Mannheimia haemolytica A2. Vet Res 51:36

    Article  CAS  Google Scholar 

  19. Ke Z, Lin H, Fan Z, Cai TQ, Kaplan RA, Ma C et al (2006) MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2. Int J Cancer 119:8–16

    Article  CAS  Google Scholar 

  20. Park MJ, Park IC, Hur JH, Rhee CH, Choe TB, Yi DH, Hong SI, Lee SH (2000) Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells. Neurosci Lett 290:201–204

    Article  CAS  Google Scholar 

  21. Serna-Marquez N, Diaz-Aragon R, Reyes-Uribe E, Cortes-Reynosa P, Salazar EP (2017) Linoleic acid induces migration and invasion through FFAR4- and PI3K-/Akt-dependent pathway in MDA-MB-231 breast cancer cells. Med Oncol 34:111

    Article  Google Scholar 

  22. Serna-Marquez N, Villegas-Comonfort S, Galindo-Hernandez O, Navarro-Tito N, Millan A, Salazar EP (2013) Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells. Cell Oncol (Dordr) 36:65–77

    Article  CAS  Google Scholar 

  23. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740–746

    Article  CAS  Google Scholar 

  24. Schaller MD (2001) Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20:6459–6472

    Article  CAS  Google Scholar 

  25. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572

    Article  CAS  Google Scholar 

  26. Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374

    Article  CAS  Google Scholar 

  27. Tang L, Cui T, Wu JJ, Liu-Mares W, Huang N, Li J (2010) A rice-derived recombinant human lactoferrin stimulates fibroblast proliferation, migration, and sustains cell survival. Wound Repair Regen 18:123–131

    Article  Google Scholar 

  28. Takayama Y, Mizumachi K (2001) Effects of lactoferrin on collagen gel contractile activity and myosin light chain phosphorylation in human fibroblasts. FEBS Lett 508:111–116

    Article  CAS  Google Scholar 

  29. Simopoulos AP (2006) Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60:502–507

    Article  CAS  Google Scholar 

  30. Tsubura A, Uehara N, Kiyozuka Y, Shikata N (2005) Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia 10:87–100

    Article  Google Scholar 

  31. Lee MM, Lin SS (2000) Dietary fat and breast cancer. Annu Rev Nutr 20:221–248

    Article  CAS  Google Scholar 

  32. Buja A, Pierbon M, Lago L, Grotto G, Baldo V (2020): Breast Cancer Primary Prevention and Diet: An Umbrella Review. Int J Environ Res Public Health 17

  33. Diaz-Aragon R, Ramirez-Ricardo J, Cortes-Reynosa P, Simoni-Nieves A, Gomez-Quiroz LE, Perez Salazar E (2019) Role of phospholipase D in migration and invasion induced by linoleic acid in breast cancer cells. Mol Cell Biochem 457:119–132

    Article  CAS  Google Scholar 

  34. Gibbons JA, Kanwar JR, Kanwar RK (2015) Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer. BMC Cancer 15:425

    Article  Google Scholar 

  35. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131–142

    Article  CAS  Google Scholar 

  36. Ziegler E, Hansen MT, Haase M, Emons G, Grundker C (2014) Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo. Breast Cancer Res Treat 148:269–277

    Article  CAS  Google Scholar 

  37. Dai X, Cheng H, Bai Z, Li J (2017) Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subty**. J Cancer 8:3131–3141

    Article  Google Scholar 

  38. Chao YL, Shepard CR, Wells A (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9:179

    Article  Google Scholar 

  39. Chea C, Miyauchi M, Inubushi T, Okamoto K, Haing S, Nguyen PT, Imanaka H, Takata T (2018) Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma. Biochem Biophys Res Commun 507:142–147

    Article  CAS  Google Scholar 

  40. Cutone A, Colella B, Pagliaro A, Rosa L, Lepanto MS, Bonaccorsi di Patti MC, Valenti P, Di Bartolomeo S, Musci G (2020) Native and iron-saturated bovine lactoferrin differently hinder migration in a model of human glioblastoma by reverting epithelial-to-mesenchymal transition-like process and inhibiting interleukin-6/STAT3 axis. Cell Signal 65:109461

    Article  CAS  Google Scholar 

  41. Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5:816–826

    Article  CAS  Google Scholar 

  42. Wozniak MA, Modzelewska K, Kwong L, Keely PJ (2004) Focal adhesion regulation of cell behavior. Biochim Biophys Acta 1692:103–119

    Article  CAS  Google Scholar 

  43. Parsons JT (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116:1409–1416

    Article  CAS  Google Scholar 

  44. Zhao J, Guan JL (2009) Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28:35–49

    Article  Google Scholar 

  45. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF (2004) FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6:154–161

    Article  CAS  Google Scholar 

  46. Avizienyte E, Frame MC (2005) Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 17:542–547

    Article  CAS  Google Scholar 

  47. Jeong YY, Lee GY, Yoo YC (2021) Bovine Lactoferricin Induces Intestinal Epithelial Cell Activation through Phosphorylation of FAK and Paxillin and Prevents Rotavirus Infection. J Microbiol Biotechnol 31:1175–1182

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Nora Ruiz for her technical assistance.

Funding

This research was funded by CONACYT (255429), Mexico. Grants from CONACYT supported N R-O and K R-R.

Author information

Authors and Affiliations

Authors

Contributions

N R-O, K R-R: design, conduction, data analysis, methodology, validation and manuscript preparation. P C-R, MG, EPS: Conceptualization, Methodology, Writing-Review and editing, Project administration, Funding acquisition, Visualization, Supervision.

Corresponding author

Correspondence to Eduardo Perez Salazar.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare that they have no conflicts of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodriguez-Ochoa, N., Cortes-Reynosa, P., Rodriguez-Rojas, K. et al. Bovine holo-lactoferrin inhibits migration and invasion in MDA-MB-231 breast cancer cells. Mol Biol Rep 50, 193–201 (2023). https://doi.org/10.1007/s11033-022-07943-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-022-07943-8

Keywords

Navigation